Urothelial Carcinoma of the Bladder
5 clinical trials · Condition
◉ Watch Urothelial Carcinoma of the Bladder
| Record | Firm | Date |
|---|---|---|
| AN0025 and Pembrolizumab Combination in Advanced Solid Tumors (NCT04432857) | Adlai Nortye Biopharma Co., Ltd. | 2020-08-20 |
| Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) (NCT02710734) | Fox Chase Cancer Center | 2016-02-24 |
| Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts (NCT02246738) | Abramson Cancer Center at Penn Medicine | 2014-08-01 |
| Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer (NCT01520038) | Abramson Cancer Center at Penn Medicine | 2012-01-01 |
Track Urothelial Carcinoma of the Bladder automatically
Every clearance here is in the API, with alerts when new ones post.